Treatment with Akt inhibitor LY294002 enhanced E-cadherin expression and reduced Snail and Vimentin levels, indicating that Akt activation-induced EMT promotes oral cancer cell migration and invasion. The gene discussed is SNAI1; the disease is lip and oral cavity carcinoma.